Evidence map›Paper›PMID 28059711›Full record

ArticleAJNR. American journal of neuroradiology2017

T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis.

C Thaler, T D Faizy, J Sedlacik, B Holst, K Stürner, C Heesen, J-P Stellmann, J Fiehler, S Siemonsen

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Quantitative TEuropean radiology · 2024
    Article
  3. Article
  4. Predictive MRI Biomarkers in MS-A Critical Review.Medicina (Kaunas, Lithuania) · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. A new frontier for amyloid PET imaging: multiple sclerosis.European journal of nuclear medicine and molecular imaging · 2019
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C ThalerFrom the Departments of Diagnostic and Interventional Neuroradiology (C.T., T.D.F., J.S., B.H., J.F., S.S.) c.thaler@uke.de.ORCID 0000-0002-7102-9316
T D FaizyFrom the Departments of Diagnostic and Interventional Neuroradiology (C.T., T.D.F., J.S., B.H., J.F., S.S.).ORCID 0000-0002-1631-2020
J SedlacikFrom the Departments of Diagnostic and Interventional Neuroradiology (C.T., T.D.F., J.S., B.H., J.F., S.S.).ORCID 0000-0003-3125-1083
B HolstFrom the Departments of Diagnostic and Interventional Neuroradiology (C.T., T.D.F., J.S., B.H., J.F., S.S.).ORCID 0000-0002-6762-645X
K StürnerNeurology (K.S., C.H., J.-P.S.).ORCID 0000-0003-2199-3315
C HeesenNeurology (K.S., C.H., J.-P.S.).ORCID 0000-0001-8131-9467
J-P StellmannNeurology (K.S., C.H., J.-P.S.).ORCID 0000-0003-2565-2833
J FiehlerFrom the Departments of Diagnostic and Interventional Neuroradiology (C.T., T.D.F., J.S., B.H., J.F., S.S.).ORCID 0000-0001-8533-7478
S SiemonsenFrom the Departments of Diagnostic and Interventional Neuroradiology (C.T., T.D.F., J.S., B.H., J.F., S.S.).ORCID 0000-0002-7444-7265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeQuantitative MR imaging parameters help to evaluate disease progression in multiple sclerosis and increase correlation with clinical disability. We therefore hypothesized that T1 values might be a marker for ongoing tissue damage or even remyelination and may help increase clinical correlation. MATERIALS AND

methodsMR imaging was performed in 17 patients with relapsing-remitting MS at baseline and after 12 months of starting immunotherapy with dimethyl fumarate. On baseline images, lesion segmentation was performed for normal-appearing white matter, T2 hyperintense (FLAIR lesions), T1 hypointense (black holes), and contrast-enhancing lesions, and T1 relaxation times were obtained at baseline and after 12 months. Changes in clinical status were assessed by using the Expanded Disability Status Scale and Symbol Digit Modalities Test at both dates (Expanded Disability Status Scale-difference/Symbol Digit Modalities Test-diff).

resultsThe highest T1 relaxation time at baseline was measured in black holes (1460.2 ± 209.46 ms) followed by FLAIR lesions (1400.38 ± 189.1 ms), pure FLAIR lesions (1327.5 ± 210.04 ms), contrast-enhancing lesions (1205.59 ± 199.95 ms), and normal-appearing white matter (851.34 ± 30.61 ms). After 12 months, T1 values had decreased significantly in black holes (1369.4 ± 267.81 ms), contrast-enhancing lesions (1079.57 ± 183.36 ms) (both

conclusionsT1 relaxation time is a useful quantitative MR imaging technique, which helps detect changes in MS lesions with time. We assume that these changes are associated with the degree of myelination within the lesions themselves and are pronounced in black holes. Additionally, decreasing T1 values in black holes were associated with clinical improvement.

Indexed as

AdultBrainDisease ProgressionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMultiple Sclerosis, Relapsing-RemittingRecurrenceWhite Matter

Identifiers

PMID28059711
PMCPMC7963813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.